Feasibility of Closed-loop TCI Based on New EEG Baseline in the Presence of Low Dose of Esketamine
Clinical trial NCT06729892 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06729892
- Sponsor
- bo xu
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-20
- Primary completion
- 2025-04-30
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.